A critical appraisal of ‘Shingrix’, a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

(2016) Anthony L. Cunningham et al.   NEW ENGLAND JOURNAL OF MEDICINE

A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children

(2016) Jorgen Stassijns et al.   VACCINE

Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults

(2016) Roman Chlibek et al.   VACCINE

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

(2015) Himal Lal et al.   NEW ENGLAND JOURNAL OF MEDICINE

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients

(2014) E. A. Stadtmauer et al.   BLOOD

Long-term Persistence of Zoster Vaccine Efficacy

(2014) Vicki A. Morrison et al.   CLINICAL INFECTIOUS DISEASES

Molecular mechanisms of varicella zoster virus pathogenesis

(2014) Leigh Zerboni et al.   NATURE REVIEWS MICROBIOLOGY

Vaccines for preventing herpes zoster in older adults

(2014) Ana M. Z. Gagliardi et al.   Sao Paulo Medical Journal

Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

(2014) Roman Chlibek et al.   VACCINE

Systematic review of incidence and complications of herpes zoster: towards a global perspective

(2014) K. Kawai et al.   BMJ Open

Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites

(2014)   PLOS MEDICINE

Decreasing Incidence of Herpes Zoster in the Highly Active Antiretroviral Therapy Era

(2013) A. Moanna et al.   CLINICAL INFECTIOUS DISEASES

Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age

(2013) R. Chlibek et al.   JOURNAL OF INFECTIOUS DISEASES

Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy

(2012) K. E. Schmader et al.   CLINICAL INFECTIOUS DISEASES

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

(2012) Isabel Leroux-Roels et al.   JOURNAL OF INFECTIOUS DISEASES

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

(2012) Holger Thiele et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice

(2012) Najoua Dendouga et al.   VACCINE

Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

(2010) Anne A. Gershon et al.   JOURNAL OF CLINICAL VIROLOGY

Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine

(2009) Adriana Weinberg et al.   JOURNAL OF INFECTIOUS DISEASES

Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine

(2008) M. J. Levin et al.   JOURNAL OF INFECTIOUS DISEASES

Humoral and Cellular Immunity to Varicella‐Zoster Virus: An Overview

(2008) Ann M. Arvin   JOURNAL OF INFECTIOUS DISEASES